[go: up one dir, main page]

ES537826A0 - Procedimiento para preparar sustancias proteinicas anti-tumorales - Google Patents

Procedimiento para preparar sustancias proteinicas anti-tumorales

Info

Publication number
ES537826A0
ES537826A0 ES537826A ES537826A ES537826A0 ES 537826 A0 ES537826 A0 ES 537826A0 ES 537826 A ES537826 A ES 537826A ES 537826 A ES537826 A ES 537826A ES 537826 A0 ES537826 A0 ES 537826A0
Authority
ES
Spain
Prior art keywords
procedure
tumor protein
preparing anti
protein substances
substances
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES537826A
Other languages
English (en)
Other versions
ES8604400A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyorin Pharmaceutical Co Ltd
Original Assignee
Kyorin Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Pharmaceutical Co Ltd filed Critical Kyorin Pharmaceutical Co Ltd
Publication of ES537826A0 publication Critical patent/ES537826A0/es
Publication of ES8604400A1 publication Critical patent/ES8604400A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/14—Lymphokine; related peptides
    • Y10S930/144—Tumor necrosis factor

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ES537826A 1983-11-21 1984-11-21 Procedimiento para preparar sustancias proteinicas anti-tumorales Expired ES8604400A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58218985A JPS60112718A (ja) 1983-11-21 1983-11-21 抗腫瘍作用を示す蛋白性物質及びその製造方法

Publications (2)

Publication Number Publication Date
ES537826A0 true ES537826A0 (es) 1986-01-16
ES8604400A1 ES8604400A1 (es) 1986-01-16

Family

ID=16728457

Family Applications (1)

Application Number Title Priority Date Filing Date
ES537826A Expired ES8604400A1 (es) 1983-11-21 1984-11-21 Procedimiento para preparar sustancias proteinicas anti-tumorales

Country Status (10)

Country Link
US (1) US4777241A (es)
EP (1) EP0149751A3 (es)
JP (1) JPS60112718A (es)
KR (1) KR850003729A (es)
AU (1) AU579119B2 (es)
DK (1) DK549584A (es)
ES (1) ES8604400A1 (es)
HU (1) HU194584B (es)
IN (1) IN160606B (es)
MX (1) MX7655E (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59141519A (ja) * 1983-01-31 1984-08-14 Otsuka Pharmaceut Co Ltd 制ガン作用を有する蛋白質
US5095095A (en) * 1984-03-23 1992-03-10 Sandoz Ltd. Immunosuppressant factor protein capable of inhibiting T-cell mechanisms
US4879226A (en) * 1984-04-06 1989-11-07 Asahi Kasei Kogyo Kabushiki Kaisha Novel human physiologically active polypeptide
JPH02502999A (ja) * 1987-04-14 1990-09-20 ボード・オブ・リージェンツ，ザ・ユニバーシティ・オブ・テキサス・システム 細胞溶解因子
US5574134A (en) * 1989-07-11 1996-11-12 University Of Delaware Polypeptide monomers, linearly extended and/or crosslinked forms thereof, and applications thereof
US5242692A (en) * 1990-07-10 1993-09-07 Bar Ilan University Anti-metastatic factor
JP3439490B2 (ja) * 1992-09-28 2003-08-25 株式会社林原生物化学研究所 蛋白質とその蛋白質をコードするｄｎａ並びにその蛋白質の製造方法
JP3552240B2 (ja) * 1993-02-23 2004-08-11 第一製薬株式会社 高濃度ｔｃｆ製剤
WO1996013586A2 (en) * 1994-10-26 1996-05-09 Nobuko Satomi Histiocyte-secreted factor (hsf)
JP4006058B2 (ja) * 1997-03-11 2007-11-14 第一三共株式会社 多臓器不全予防及び／又は治療剤
DK0950416T3 (da) * 1997-03-14 2007-02-26 Daiichi Seiyaku Co Anvendelse af TCF-II til behandling af cancerrelateret tab af kropsvægt, anæmi og TNF-forhöjelse
AU2003298816C1 (en) 2002-12-02 2010-12-16 Amgen Fremont, Inc. Antibodies directed to Tumor Necrosis Factor and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8204382L (sv) * 1981-07-21 1983-01-22 Hayashibara Biochem Lab Sett att framstella malcellysfaktor och anvendning derav
US4481137A (en) * 1982-02-26 1984-11-06 Mochida Pharmaceutical Co., Ltd. Glycoproteins and processes for their production
JPS5927830A (ja) * 1982-08-09 1984-02-14 Cosmo Co Ltd 抗腫瘍性糖蛋白質物質
JPS59141519A (ja) * 1983-01-31 1984-08-14 Otsuka Pharmaceut Co Ltd 制ガン作用を有する蛋白質
JPH0695939B2 (ja) * 1983-12-02 1994-11-30 大日本製薬株式会社 ウサギ癌壊死因子をコ−ドするクロ−ン化ｄνａ
DE19975063I2 (de) * 1984-03-06 2005-08-18 Dainippon Pharmaceutical Co DNS den menschlichen Tumornekrosisfaktor kodierendund das menschliche Tumornekronisfaktor-Polypepti d.

Also Published As

Publication number Publication date
KR850003729A (ko) 1985-06-26
IN160606B (es) 1987-07-18
HU194584B (en) 1988-02-29
HUT36863A (en) 1985-10-28
MX7655E (es) 1990-06-11
DK549584D0 (da) 1984-11-20
EP0149751A2 (en) 1985-07-31
EP0149751A3 (en) 1986-07-16
JPS60112718A (ja) 1985-06-19
DK549584A (da) 1985-06-21
US4777241A (en) 1988-10-11
ES8604400A1 (es) 1986-01-16
AU579119B2 (en) 1988-11-17
AU3565884A (en) 1985-05-30

Similar Documents

Publication Publication Date Title
ES534787A0 (es) Procedimiento para preparar etinglicoles
ES529282A0 (es) Procedimiento para preparar derivados de tiazol
ES557048A0 (es) Procedimiento para preparar peptidos triofluormetilcetona-sustituidos
ES537992A0 (es) Procedimiento para preparar 2-fenil-imidazoles
ES536138A0 (es) Procedimiento para preparar derivados azolicos
MX161186A (es) Procedimiento para preparar peptidos
ES533995A0 (es) Procedimiento para preparar imidasoles
ES533538A0 (es) Procedimiento para la obtencion de tetrahidropiridazinonas
ES539255A0 (es) Procedimiento para preparar derivados de isoquinoleina
MX7572E (es) Procedimiento para preparar proteina unicelular
ES543973A0 (es) Procedimiento para preparar peptidos
ES535534A0 (es) Procedimiento para la obtencion de -aril-1h-azol-1-etanoles
MX162759A (es) Procedimiento para preparar derivados de la cumarina
ES537826A0 (es) Procedimiento para preparar sustancias proteinicas anti-tumorales
MX157033A (es) Procedimiento para preparar derivados de pirrolo quinoleina
ES534227A0 (es) Procedimiento para preparar piridinas
MX159631A (es) Procedimiento para preparar compuestos(2-imidazolin-2-il)-tieno-y furopiridinas
ES534800A0 (es) Procedimiento para preparar ciclopeptidos
ES534377A0 (es) Procedimiento para preparar derivados de antraciclina
MX7403E (es) Procedimiento para preparar derivados de benzoil-ureas
ES551695A0 (es) Procedimiento para preparar proteinas eventualmente glicosiladas
ES530037A0 (es) Procedimiento para preparar imidazolamidas
ES533024A0 (es) Procedimiento para preparar meta-o para-isopropenil-alfa-alfa-dimetilbencilamina
ES530626A0 (es) Procedimiento para preparar derivados de ciano-2-imidazopiridina
ES545868A0 (es) Procedimiento para preparar peptidos

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19960603